Exact Mass: 557.1897016
Exact Mass Matches: 557.1897016
Found 220 metabolites which its exact mass value is equals to given mass value 557.1897016
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Azidopine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
Rhodomycin D
An anthracycline that is aklavinone having a 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl residue attached at position 4 via a glycosidic linkage.
(R,E)-N-(4-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)piperidine-1-carbonyl)phenyl)-4-(dimethylamino)but-2-enamide
C30H32ClN7O2 (557.2305881999999)
Acrimarine N
Acrimarine N is found in citrus. Acrimarine N is an alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) x Dancy tangerine (Citrus tangerina)]. Alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) x Dancy tangerine (Citrus tangerina)]. Acrimarine N is found in citrus.
ceritinib
C28H36ClN5O3S (557.2227256000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Cys Cys Phe Trp
Cys Cys Trp Phe
Cys Phe Cys Trp
Cys Phe Trp Cys
Cys Ser Trp Tyr
Cys Ser Tyr Trp
Cys Trp Cys Phe
Cys Trp Phe Cys
Cys Trp Ser Tyr
Cys Trp Tyr Ser
Cys Tyr Ser Trp
Cys Tyr Trp Ser
Asp Phe Asn Tyr
Asp Phe Tyr Asn
Asp His Met Arg
Asp His Arg Met
Asp His Thr Trp
Asp His Trp Thr
Asp Met His Arg
Asp Met Arg His
Asp Asn Phe Tyr
Asp Asn Tyr Phe
Asp Arg His Met
Asp Arg Met His
Asp Thr His Trp
Asp Thr Trp His
Asp Trp His Thr
Asp Trp Thr His
Asp Tyr Phe Asn
Asp Tyr Asn Phe
Glu His Ser Trp
Glu His Trp Ser
Glu Ser His Trp
Glu Ser Trp His
Glu Trp His Ser
Glu Trp Ser His
Phe Cys Cys Trp
Phe Cys Trp Cys
Phe Asp Asn Tyr
Phe Asp Tyr Asn
Phe Phe Met Asn
C27H35N5O6S (557.2307930000001)
Phe Phe Asn Met
C27H35N5O6S (557.2307930000001)
Phe Met Phe Asn
C27H35N5O6S (557.2307930000001)
Phe Met Asn Phe
C27H35N5O6S (557.2307930000001)
Phe Asn Asp Tyr
Phe Asn Phe Met
C27H35N5O6S (557.2307930000001)
Phe Asn Met Phe
C27H35N5O6S (557.2307930000001)
Phe Asn Tyr Asp
Phe Trp Cys Cys
Phe Tyr Asp Asn
Phe Tyr Asn Asp
His Asp Met Arg
His Asp Arg Met
His Asp Thr Trp
His Asp Trp Thr
His Glu Ser Trp
His Glu Trp Ser
His Met Asp Arg
His Met Arg Asp
His Arg Asp Met
His Arg Met Asp
His Ser Glu Trp
His Ser Trp Glu
His Thr Asp Trp
His Thr Trp Asp
His Trp Asp Thr
His Trp Glu Ser
His Trp Ser Glu
His Trp Thr Asp
Met Asp His Arg
Met Asp Arg His
Met Phe Phe Asn
C27H35N5O6S (557.2307930000001)
Met Phe Asn Phe
C27H35N5O6S (557.2307930000001)
Met His Asp Arg
Met His Arg Asp
Met Met Asn Tyr
C23H35N5O7S2 (557.1977800000001)
Met Met Tyr Asn
C23H35N5O7S2 (557.1977800000001)
Met Asn Phe Phe
C27H35N5O6S (557.2307930000001)
Met Asn Met Tyr
C23H35N5O7S2 (557.1977800000001)
Met Asn Tyr Met
C23H35N5O7S2 (557.1977800000001)
Met Arg Asp His
Met Arg His Asp
Met Tyr Met Asn
C23H35N5O7S2 (557.1977800000001)
Met Tyr Asn Met
C23H35N5O7S2 (557.1977800000001)
Asn Asp Phe Tyr
Asn Asp Tyr Phe
Asn Phe Asp Tyr
Asn Phe Phe Met
C27H35N5O6S (557.2307930000001)
Asn Phe Met Phe
C27H35N5O6S (557.2307930000001)
Asn Phe Tyr Asp
Asn Met Phe Phe
C27H35N5O6S (557.2307930000001)
Asn Met Met Tyr
C23H35N5O7S2 (557.1977800000001)
Asn Met Tyr Met
C23H35N5O7S2 (557.1977800000001)
Asn Tyr Asp Phe
Asn Tyr Phe Asp
Asn Tyr Met Met
C23H35N5O7S2 (557.1977800000001)
Arg Asp His Met
Arg Asp Met His
Arg His Asp Met
Arg His Met Asp
Arg Met Asp His
Arg Met His Asp
Ser Cys Trp Tyr
Ser Cys Tyr Trp
Ser Glu His Trp
Ser Glu Trp His
Ser His Glu Trp
Ser His Trp Glu
Ser Trp Cys Tyr
Ser Trp Glu His
Ser Trp His Glu
Ser Trp Tyr Cys
Ser Tyr Cys Trp
Ser Tyr Trp Cys
Thr Asp His Trp
Thr Asp Trp His
Thr His Asp Trp
Thr His Trp Asp
Thr Trp Asp His
Thr Trp His Asp
Trp Cys Cys Phe
Trp Cys Phe Cys
Trp Cys Ser Tyr
Trp Cys Tyr Ser
Trp Asp His Thr
Trp Asp Thr His
Trp Glu His Ser
Trp Glu Ser His
Trp Phe Cys Cys
Trp His Asp Thr
Trp His Glu Ser
Trp His Ser Glu
Trp His Thr Asp
Trp Ser Cys Tyr
Trp Ser Glu His
Trp Ser His Glu
Trp Ser Tyr Cys
Trp Thr Asp His
Trp Thr His Asp
Trp Tyr Cys Ser
Trp Tyr Ser Cys
Tyr Cys Ser Trp
Tyr Cys Trp Ser
Tyr Asp Phe Asn
Tyr Asp Asn Phe
Tyr Phe Asp Asn
Tyr Phe Asn Asp
Tyr Met Met Asn
C23H35N5O7S2 (557.1977800000001)
Tyr Met Asn Met
C23H35N5O7S2 (557.1977800000001)
Tyr Asn Asp Phe
Tyr Asn Phe Asp
Tyr Asn Met Met
C23H35N5O7S2 (557.1977800000001)
Tyr Ser Cys Trp
Tyr Ser Trp Cys
Tyr Trp Cys Ser
Tyr Trp Ser Cys
Acrimarine N
Bitolterol mesylate
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
[1,1-Biphenyl]-4-carboxaldehyde,4-[bis(4-formyl[1,1-biphenyl]-4-yl)amino]-
Aristoloterpenate-I
A sesquiterpenoid obtained by formal condensation of the carboxy group of aristolochic acid with the hydroxy group of (1R,2Z,6E,10E)-3-formyl-7,11-dimethylcyclododeca-2,6,10-trien-1-ol.
ceritinib
C28H36ClN5O3S (557.2227256000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
Pixantrone maleate
C25H27N5O10 (557.1757842000001)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
(2R,4S)-4-[(2R,4S,5S,6S)-4-azaniumyl-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
(2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylic acid
(2-amino-2-oxoethyl)-[(E)-3-[7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium
4-[6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl]benzene-1,3-disulfonate
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes
3-(2,4-dimethoxyphenyl)-N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-2-oxoethyl]-4-oxo-1-phthalazinecarboxamide
(1R,2R,4S)-4-[(3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
N-(2-{3,4-bis[(4-methylbenzoyl)oxy]phenyl}-2-hydroxyethyl)-2-methylpropan-2-aminium mesylate
(2-amino-2-oxoethyl)-[(E)-3-[(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium
N-[[(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[[(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
N-[[(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-fluoro-N-methylbenzenesulfonamide
2-fluoro-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
FMN-L-threonine
A L-threonine derivative that is L-threonine attached via its side-chain to FMN via a phosphate linkage.
10-Carboxy-13-deoxydaunorubicin
An anthracycline antibiotic that is 13-deoxydaunorubicin substituted at position 10 by a carboxy group.
N-[(2R)-2-{3,4-bis[(4-methylbenzoyl)oxy]phenyl}-2-hydroxyethyl]-2-methylpropan-2-aminium methanesulfonate
3-[[3-acetyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
Azidopine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
10-carboxy-13-deoxydaunorubicin zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the primary amino group of 10-carboxy-13-deoxydaunorubicin; major species at pH 7.3.